Eli Lilly (LLY) Construction in Progress (2012 - 2024)

Eli Lilly has reported Construction in Progress for 13 years, with the latest figure at $8.2 billion in Q4 2024.

• For the quarter ending Q4 2024, Construction in Progress rose 62.17% year-over-year to $8.2 billion; the trailing twelve-month figure through Dec 2024 stood at $8.2 billion (up 62.17% YoY), and the FY2024 full-year result was $8.2 billion, up 62.17% from the prior year.
• Construction in Progress for Q4 2024 stood at $8.2 billion, up from $5.1 billion in the prior quarter.
• The five-year high for Construction in Progress was $8.2 billion in Q4 2024, with the low at $2.1 billion in Q4 2020.
• Historically, Construction in Progress has averaged $4.1 billion across 5 years, with a median of $2.8 billion in 2022.
• Annual changes were most pronounced in 2021 — Construction in Progress climbed 1.82% — and 2023, when it soared 81.67%.
• Eli Lilly's Construction in Progress stood at $2.1 billion in 2020, then increased by 1.82% to $2.2 billion in 2021, then advanced by 28.51% to $2.8 billion in 2022, then jumped by 81.67% to $5.1 billion in 2023, then soared by 62.17% to $8.2 billion in 2024.
• The last three Construction in Progress figures came in at $8.2 billion (Q4 2024), $5.1 billion (Q4 2023), and $2.8 billion (Q4 2022), per Business Quant data.